TG Therapeutics Inc (TGTX)
16.48
-0.94
(-5.40%)
USD |
NASDAQ |
May 17, 16:00
16.48
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Free Cash Flow: 20.28M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.28M |
| December 31, 2023 | -31.41M |
| September 30, 2023 | -42.07M |
| June 30, 2023 | -160.27M |
| March 31, 2023 | -167.38M |
| December 31, 2022 | -176.18M |
| September 30, 2022 | -239.30M |
| June 30, 2022 | -272.08M |
| March 31, 2022 | -283.31M |
| December 31, 2021 | -296.04M |
| September 30, 2021 | -261.23M |
| June 30, 2021 | -250.57M |
| March 31, 2021 | -234.10M |
| December 31, 2020 | -214.86M |
| September 30, 2020 | -193.11M |
| June 30, 2020 | -169.76M |
| March 31, 2020 | -161.76M |
| December 31, 2019 | -132.94M |
| September 30, 2019 | -136.21M |
| June 30, 2019 | -135.97M |
| March 31, 2019 | -134.31M |
| December 31, 2018 | -129.02M |
| September 30, 2018 | -117.17M |
| June 30, 2018 | -106.91M |
| March 31, 2018 | -99.53M |
| Date | Value |
|---|---|
| December 31, 2017 | -93.76M |
| September 30, 2017 | -88.95M |
| June 30, 2017 | -81.23M |
| March 31, 2017 | -67.28M |
| December 31, 2016 | -61.93M |
| September 30, 2016 | -57.77M |
| June 30, 2016 | -53.42M |
| March 31, 2016 | -52.80M |
| December 31, 2015 | -44.73M |
| September 30, 2015 | -46.97M |
| June 30, 2015 | -44.32M |
| March 31, 2015 | -35.64M |
| December 31, 2014 | -35.08M |
| September 30, 2014 | -24.78M |
| June 30, 2014 | -17.89M |
| March 31, 2014 | -16.87M |
| December 31, 2013 | -10.74M |
| September 30, 2013 | -6.752M |
| June 30, 2013 | -8.589M |
| March 31, 2013 | -6.532M |
| December 31, 2012 | -5.189M |
| September 30, 2012 | -4.412M |
| June 30, 2012 | -1.449M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0866M |
Free Cash Flow Range, Past 5 Years
-296.04M
Minimum
Dec 2021
20.28M
Maximum
Mar 2024
-176.91M
Average
-172.97M
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics Inc | -88.03M |
| Geron Corp | -184.70M |
| Editas Medicine Inc | -151.03M |
| G1 Therapeutics Inc | -18.18M |
| Mersana Therapeutics Inc | -173.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.207M |
| Cash from Investing (Quarterly) | -9.255M |
| Cash from Financing (Quarterly) | 0.01M |
| Free Cash Flow Per Share (Quarterly) | -0.0561 |
| Free Cash Flow to Equity (Quarterly) | -9.415M |
| Free Cash Flow to Firm (Quarterly) | -5.913M |
| Free Cash Flow Yield | 0.82% |